1. Home
  2. ATAI vs FF Comparison

ATAI vs FF Comparison

Compare ATAI & FF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • FF
  • Stock Information
  • Founded
  • ATAI 2018
  • FF N/A
  • Country
  • ATAI Germany
  • FF United States
  • Employees
  • ATAI N/A
  • FF N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • FF Major Chemicals
  • Sector
  • ATAI Health Care
  • FF Industrials
  • Exchange
  • ATAI Nasdaq
  • FF Nasdaq
  • Market Cap
  • ATAI 222.3M
  • FF 230.8M
  • IPO Year
  • ATAI 2021
  • FF N/A
  • Fundamental
  • Price
  • ATAI $1.50
  • FF $5.51
  • Analyst Decision
  • ATAI Strong Buy
  • FF Strong Buy
  • Analyst Count
  • ATAI 4
  • FF 1
  • Target Price
  • ATAI $9.00
  • FF $0.80
  • AVG Volume (30 Days)
  • ATAI 1.9M
  • FF 224.2K
  • Earning Date
  • ATAI 11-13-2024
  • FF 03-13-2025
  • Dividend Yield
  • ATAI N/A
  • FF 4.38%
  • EPS Growth
  • ATAI N/A
  • FF 24.25
  • EPS
  • ATAI N/A
  • FF 0.82
  • Revenue
  • ATAI $331,000.00
  • FF $273,839,000.00
  • Revenue This Year
  • ATAI $80.07
  • FF N/A
  • Revenue Next Year
  • ATAI N/A
  • FF N/A
  • P/E Ratio
  • ATAI N/A
  • FF $6.52
  • Revenue Growth
  • ATAI N/A
  • FF N/A
  • 52 Week Low
  • ATAI $1.03
  • FF $4.15
  • 52 Week High
  • ATAI $2.85
  • FF $8.36
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 52.34
  • FF 62.33
  • Support Level
  • ATAI $1.36
  • FF $5.09
  • Resistance Level
  • ATAI $1.50
  • FF $5.51
  • Average True Range (ATR)
  • ATAI 0.15
  • FF 0.14
  • MACD
  • ATAI -0.00
  • FF 0.04
  • Stochastic Oscillator
  • ATAI 41.43
  • FF 96.51

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

About FF FutureFuel Corp. Common shares

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

Share on Social Networks: